Seeking an optimal dosing regimen for OZ439-DSM265 combination therapy for treating uncomplicated falciparum malaria
S. Dini, S. G. Zaloumis, D. J. Price, N. Gobeau, A. Kuemmel, M. Cherkaoui, J. J. Moehrle, J. S. McCarthy, J. A. Simpson
This study uses a mathematical model to determine an optimal dosing regimen for OZ439-DSM265 combination therapy to treat uncomplicated falciparum malaria, predicting a regimen that cures 90% of patients within 42 days.
bioRxiv · Nov 2, 2020Pharmacology & Toxicology